NEREUS Capsule Ref.[116150] Active ingredients: Tradipitant

Source: FDA, National Drug Code (US)  Revision Year: 2026 

Product description

NEREUS (tradipitant) is a substance P/neurokinin-1 (NK-1) receptor antagonist designated by the chemical name, as {2-[1-(3,5-Bistrifluoromethylbenzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4- yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone, with molecular formula C28H16ClF6N5O, and molecular weight 587.9. The chemical structure for tradipitant is:

Tradipitant is a white to off-white crystalline powder. It is practically insoluble in water, soluble in methanol, and slightly soluble in isopropyl alcohol and simulated gastric fluid.

NEREUS is supplied as white opaque body capsules with "VANDA 85mg" printed in white on the black opaque cap for oral administration, each containing 85 mg tradipitant. Inactive ingredients are croscarmellose sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose, povidone, and sodium lauryl sulfate. The capsule contains FD&C blue No 1, FD&C red No 40, and FD&C yellow No 6, gelatin, and titanium dioxide.

Dosage Forms and Strengths

Capsules: 85 mg, supplied as a white opaque body capsule with "VANDA 85mg" printed on the black opaque cap.

How Supplied

NEREUS (tradipitant) capsules 85 mg are supplied as white opaque body with "VANDA 85mg" printed in white on the black opaque cap and packaged as 36-count in an HDPE bottle with child-resistant cap and a 2-g desiccant pouch.

  • NDC 43068-585-02 Bottles of 36

Distributed By: Vanda Pharmaceuticals Inc., Washington, D.C. 20037 USA

Drugs

Drug Countries
NEREUS United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.